Tatva Chintan Pharma Chem Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1628.3
- Today's High:
- ₹1689.3
- Open Price:
- ₹1685
- 52W Low:
- ₹1581.6
- 52W High:
- ₹2649.1001
- Prev. Close:
- ₹1679.4
- Volume:
- 7419
Company Statistics
- Market Cap.:
- ₹38.79 billion
- Book Value:
- 232.284
- Revenue TTM:
- ₹4.50 billion
- Operating Margin TTM:
- 13.52%
- Gross Profit TTM:
- ₹2.06 billion
- Profit Margin:
- 10.05%
- Return on Assets TTM:
- 5.15%
- Return on Equity TTM:
- 9.21%
Company Profile
Tatva Chintan Pharma Chem Limited had its IPO on under the ticker symbol TATVA.
The company operates in the Basic Materials sector and Specialty Chemicals industry. Tatva Chintan Pharma Chem Limited has a staff strength of 0 employees.
Stock update
Shares of Tatva Chintan Pharma Chem Limited opened at ₹1685 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1628.3 - ₹1689.3, and closed at ₹1651.65.
This is a -1.65% slip from the previous day's closing price.
A total volume of 7,419 shares were traded at the close of the day’s session.
In the last one week, shares of Tatva Chintan Pharma Chem Limited have slipped by -4.95%.
Tatva Chintan Pharma Chem Limited's Key Ratios
Tatva Chintan Pharma Chem Limited has a market cap of ₹38.79 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Tatva Chintan Pharma Chem Limited’s revenue was ₹4.50 billion with a gross profit of ₹2.06 billion and an EBITDA of ₹707.45 million. The EBITDA ratio measures Tatva Chintan Pharma Chem Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Tatva Chintan Pharma Chem Limited’s operating margin was 13.52% while its return on assets stood at 5.15% with a return of equity of 9.21%.
In Q2, Tatva Chintan Pharma Chem Limited’s quarterly earnings growth was a negative -2.9% while revenue growth was a positive 29.4%.
Tatva Chintan Pharma Chem Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 84.5386
- PEG
Its diluted EPS in the last 12-months stands at ₹20.7 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Tatva Chintan Pharma Chem Limited’s profitability.
Tatva Chintan Pharma Chem Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Tatva Chintan Pharma Chem Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.12% and a payout ratio of 9.09%.
Balance sheet and cash flow metrics
- Total Assets
- ₹7.56 billion
- Total Liabilities
- ₹2.36 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 9.09%
Tatva Chintan Pharma Chem Limited ended 2024 with ₹7.56 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹7.56 billion while shareholder equity stood at ₹5.15 billion.
Tatva Chintan Pharma Chem Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹2.36 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹273.66 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹42.30 million.
Tatva Chintan Pharma Chem Limited’s total current assets stands at ₹3.14 billion while long-term investments were ₹0 and short-term investments were ₹206.42 million. Its net receivables were ₹844.03 million compared to accounts payable of ₹321.88 million and inventory worth ₹1.62 billion.
In 2024, Tatva Chintan Pharma Chem Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Tatva Chintan Pharma Chem Limited paid ₹0.09 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1651.65
- 52-Week High
- ₹2649.1001
- 52-Week Low
- ₹1581.6
- Analyst Target Price
- ₹
Tatva Chintan Pharma Chem Limited stock is currently trading at ₹1651.65 per share. It touched a 52-week high of ₹2649.1001 and a 52-week low of ₹2649.1001. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1697.45 and 200-day moving average was ₹1847.11 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7917.1% of the company’s stock are held by insiders while 1335.2% are held by institutions.
Frequently Asked Questions About Tatva Chintan Pharma Chem Limited
Similar Industry Stocks (Specialty Chemicals)
Most Active
Top Gainers
Top Losers
About
Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also engages in trading of specialty chemicals. The company serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. It also exports its products to various countries, including the United States, Singapore, the United Kingdom, China, Germany, Japan, and South Africa. The company was incorporated in 1996 and is headquartered in Vadodara, India.